Chiesi Mirum Pharmaceuticals Initiates Rolling Submission of a New Drug Application for Maralixibat Art Pappas will interview Dr. Amy Abernethy for Demy-Colton’s Virtual Salon Series Kyle Rasbach will serve on a panel at the World Orphan Drug Congress USA 2020 4D Molecular Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of 4D-125 by Intravitreal Injection for the Treatment of X-Linked Retinitis Pigmentosa Amplyx Doses First Patient in Phase 2 Clinical Trial of Anti-BKV Monoclonal Antibody in Renal Transplant Recipients Cyclerion Therapeutics Completes $24 Million Private Placement BioAtla Raises $72.5 Million In Series D Financing VelosBio Raises $137 Million in Series B Financing 4D Molecular Therapeutics Raises $75 Million in Series C Financing Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million pcopu - June 18, 2018 - No Comments
